N. Ambrosino (Gussago, Italy), N. Keaney (Sunderland, United Kingdom)
Relation of lung function with bronchoalveolar lavage cell findings in mild to moderate COPD
D. Ozol, T. Aysan, Z. Aytemur Solak, A. Veral, F. Sebik (Izmir, Turkey)
|  |
Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma
R. W. Dal Negro, M. Visconti, S. Tognella, C. Micheletto, C. Pomari, F. Trevisan (Bussolengo, Italy)
| |
Exacerbation aetiology and inflammation markers in chronic obstructive bronchitis
E. A. Dementyeva, S. V. Nesterovich, G. N. Seitova, E. B. Bukreeva, O. E. Akbasheva, N. M. Shevtcova, L. V. Goudkova (Tomsk, Russia)
| |
Leptin and inflammatory cytokines during COPD exacerbation
P. Kythreotis, N. Lolis, E. Ablianitis, P. Bakakos, A. Kokkini, E. Anastasakou, A. Rasidakis (Athens, Greece)
| |
Corticosteroid reversibility testing and exhaled leukotriene B4 in patients with stable, severe COPD
W. A. Biernacki, S. A. Kharitonov, P. J. Barnes (London, United Kingdom)
| |
Biomarkers of COPD severity in expired air condensate
A. E. Makarevich (Minsk, Belarus)
| |
Relationship between quality of life and symptom scores in COPD outpatients
S. Plavsic, B. S. Gvozdenovic, M. Vukovic (Kraljevo, Serbia; Belgrade, Yugoslavia)
| |
Relationship between health-related quality of life and pulmonary function in COPD outpatients
S. Plavsic, B. S. Gvozdenovic, M. Vukovic, S. Milosevic, V. Stanisavljevic (Kraljevo, Serbia; Belgrade, Yugoslavia)
| |
Effects of nutritional status on dyspnea in patients with COPD
G. Pitsiou, A. Antoniadis, P. Stefanopoulou, A. Gavriilidou, N. Galanis, D. Patakas (Thessaloniki, Greece)
| |
Quality of life and cardiorespiratory system in COPD
L. K. Suleyeva, S. S. Panina, V. N. Kontzur, T. L. Vasylyeva (Dnepropetrovsk, Ukraine)
| |
The integration of immune system changes and febrile reaction induced by pyrogenal injection in advanced COPD
A. E. Makarevich (Minsk, Belarus)
| |
GOLD launch in Kyrgyzstan: problems and barriers
N. N. Brimkulov, T. K. Mergenbaeva, D. V. Vinnikov, R. A. Cholurova (Bishkek, Kyrgyzstan)
| |
GOLD launch in Ryazan, Russia
D. R. Rackita, V. G. Makarova, V. Y. Garmash, D. D. Rackita (Ryazan, Russia)
| |
The current ERS, BTS, ATS and GOLD classification criteria underestimate the impact of COPD on patients
A. D. Lawrence, N. P. Keaney (Sunderland, United Kingdom)
| |
Implementing the BTS COPD guidelines: how far have we come?
D. M. G. Halpin, M. Rudolf, B.T.S. COPD Consortium (Exeter, United Kingdom)
| |
Breathlessness and its relationship to changes in spirometry during exacerbations of chronic bronchitis
A. J. White, S. L. Hill, R. A. Stockley (Birmingham, United Kingdom)
| |
Chronic obstructive pulmonary disease is an independent risk factor for nonsmall cell lung cancer in smokers
G. L. Casoni, G. Caramori, N. Calia, F. Ravenna, F. Braccioni, G. Cavallesco, L. M. Fabbri, A. Papi, A. Ciaccia (Ferrara, Tresigallo, Modena, Italy; London, United Kingdom)
| |
Carboxyhemoglobin (COHb) and bilirubin levels increase with acute exacerbations of chronic obstructive pulmonary disease (COPD)
S. Petruzzelli, L. M. Tavanti, M. Luperini, M. Serradori, C. Giuntini (Pisa, Italy)
| |
Predictors for the rapid decline of FEV1 in chronic obstructive lung disease
D. Ozol, S. Oktem, M. Erdinc, G. Cok, E. Erdinc (Izmir, Turkey)
| |
Inspiratory flow rates in chronic obstructive pulmonary disease
T. Demir, H. Demirel, N. Yildirim (Istanbul, Turkey)
| |